Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR4 | P22455 | 2/20 | 0.36 |
| ▸ | SIK1 | P57059 | 2/20 | 0.35 |
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.35 |
| ▸ | SIK3 | Q9Y2K2 | 2/20 | 0.35 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.35 |
| ▸ | NUAK2 | Q9H093 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 12/20 | 0.32 |
| ▸ | CSF1R | P07333 | 11/20 | 0.32 |
| ▸ | WEE1 | P30291 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5231241 | 0.79 | FGFR4 (0.52) | FGFR4SIK1SIK2SIK3MAPK14 | |
| SCHEMBL6619372 | 0.77 | FGFR4 (0.42) | FGFR4SIK1SIK2SIK3NUAK1 | |
| SCHEMBL6619490 | 0.77 | MAPK14 (0.42) | FGFR4SIK2MAPK14LCKUSP2 | |
| SCHEMBL6619216 | 0.76 | MAPK14 (0.42) | FGFR4SIK1SIK2SIK3MAPK14 | |
| SCHEMBL6618524 | 0.74 | FGFR4 (0.44) | FGFR4MAPK14LCKTP53MAPT | |
| SCHEMBL6619197 | 0.74 | FGFR4 (0.47) | FGFR4SIK1SIK2SIK3MAPK14 | |
| SCHEMBL6620449 | 0.73 | LCK (0.73) | FGFR4SIK2MAPK14LCKEGFR | |
| SCHEMBL6620496 | 0.71 | FGFR4 (0.39) | FGFR4MAPK14LCKMAPT | |
| SCHEMBL6622980 | 0.70 | MAPK14 (0.43) | FGFR4SIK1SIK2SIK3NUAK1 | |
| SCHEMBL6622657 | 0.69 | FGFR4 (0.42) | FGFR4MAPK14LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1123295-B1 | BICYCLIC NITROGEN HETEROCYCLES | HOFFMANN LA ROCHE (CH) | 2004-09-29 | — | — | EP | disclosed |
| EP-1123295-A1 | BICYCLIC NITROGEN HETEROCYCLES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-08-16 | — | — | EP | disclosed |
| US-6150373-A | AMINO-SUBSTITUTED DIHYDROPYRIMIDO(4,5-D)PYRIMIDINONE DERIVATIVES; INHIBITORS OF THE T-CELL TYROSINE KINASE P56LCK; IMMUNOSUPPRESSANTS; ANTIINFLAMMATORY/-CARCINOGENIC AGENTS; BRONCHOPULMONARY, DERMATOLOGICAL AND CARDIOVASCULAR DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 2000-11-21 | — | — | US | disclosed |
| WO-2000024744-A1 | BICYCLIC NITROGEN HETEROCYCLES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-05-04 | — | — | WO | disclosed |